{"id":"https://openalex.org/W2621391008","doi":"https://doi.org/10.1007/s12094-017-1684-4","title":"Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spain","display_name":"Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spain","publication_year":2017,"publication_date":"2017-06-02","ids":{"openalex":"https://openalex.org/W2621391008","doi":"https://doi.org/10.1007/s12094-017-1684-4","mag":"2621391008","pmid":"https://pubmed.ncbi.nlm.nih.gov/28577152","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5700215"},"language":"en","primary_location":{"id":"doi:10.1007/s12094-017-1684-4","doi":"https://doi.org/10.1007/s12094-017-1684-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12094-017-1684-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12094-017-1684-4.pdf","source":{"id":"https://openalex.org/S179824187","display_name":"Clinical & Translational Oncology","issn_l":"1699-048X","issn":["1699-048X","1699-3055"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s12094-017-1684-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031541143","display_name":"Guillermo L\u00f3pez-Vivanco","orcid":"https://orcid.org/0000-0003-3800-6224","observed_orcids":["https://orcid.org/0000-0003-3800-6224"]},"institutions":[{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"G. Lopez-Vivanco","raw_affiliation_strings":["Hospital de Cruces, Vizcaya, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital de Cruces, Vizcaya, Spain","institution_ids":["https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110021200","display_name":"Javier Salvador","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148397","display_name":"Hospital Universitario de Valme","ror":"https://ror.org/04cxs7048","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210148397"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Salvador","raw_affiliation_strings":["Hospital Nuestra Se\u00f1ora de Valme, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Nuestra Se\u00f1ora de Valme, Sevilla, Spain","institution_ids":["https://openalex.org/I4210148397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103230923","display_name":"R Diez","orcid":"https://orcid.org/0000-0002-9627-5337","observed_orcids":["https://orcid.org/0000-0002-9627-5337"]},"institutions":[{"id":"https://openalex.org/I4210104045","display_name":"Hospital Universitario de Getafe","ror":"https://ror.org/01ehe5s81","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210104045","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R. Diez","raw_affiliation_strings":["Hospital de Getafe, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital de Getafe, Madrid, Spain","institution_ids":["https://openalex.org/I4210104045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026870852","display_name":"D. L\u00f3pez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. L\u00f3pez","raw_affiliation_strings":["Hospital ICO Badalona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital ICO Badalona, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051016771","display_name":"Marina de Salas-Cansado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151856","display_name":"Roche (Spain)","ror":"https://ror.org/04b8zcj45","country_code":"ES","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210151856"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. De Salas-Cansado","raw_affiliation_strings":["Roche Farma SA, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Farma SA, Madrid, Spain","institution_ids":["https://openalex.org/I4210151856"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102912066","display_name":"B. Navarro","orcid":"https://orcid.org/0000-0001-5738-6790","observed_orcids":["https://orcid.org/0000-0001-5738-6790"]},"institutions":[{"id":"https://openalex.org/I4210151856","display_name":"Roche (Spain)","ror":"https://ror.org/04b8zcj45","country_code":"ES","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210151856"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"B. Navarro","raw_affiliation_strings":["Roche Farma SA, Madrid, Spain. beatriz.navarro@roche.com","Roche Farma SA, Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0001-5738-6790","affiliations":[{"raw_affiliation_string":"Roche Farma SA, Madrid, Spain. beatriz.navarro@roche.com","institution_ids":["https://openalex.org/I4210151856"]},{"raw_affiliation_string":"Roche Farma SA, Madrid, Spain","institution_ids":["https://openalex.org/I4210151856"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040158829","display_name":"Juan de la Haba-Rodr\u00edguez","orcid":"https://orcid.org/0000-0001-5111-1702","observed_orcids":["https://orcid.org/0000-0001-5111-1702"]},"institutions":[{"id":"https://openalex.org/I4210093628","display_name":"Instituto Maim\u00f3nides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba","ror":"https://ror.org/00j9b6f88","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210093628"]},{"id":"https://openalex.org/I4210123675","display_name":"Hospital Universitario Reina Sof\u00eda","ror":"https://ror.org/02vtd2q19","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210123675"]},{"id":"https://openalex.org/I53110688","display_name":"University of C\u00f3rdoba","ror":"https://ror.org/05yc77b46","country_code":"ES","type":"education","lineage":["https://openalex.org/I53110688"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. De la Haba-Rodr\u00edguez","raw_affiliation_strings":["Instituto Maim\u00f3nides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba (IMIBIC), Universidad de C\u00f3rdoba, Hospital Reina Sofia, C\u00f3rdoba, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Maim\u00f3nides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba (IMIBIC), Universidad de C\u00f3rdoba, Hospital Reina Sofia, C\u00f3rdoba, Spain","institution_ids":["https://openalex.org/I4210093628","https://openalex.org/I4210123675","https://openalex.org/I53110688"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5102912066"],"corresponding_institution_ids":["https://openalex.org/I4210151856"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":5.061,"has_fulltext":true,"cited_by_count":54,"citation_normalized_percentile":{"value":0.95060592,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"19","issue":"12","first_page":"1454","last_page":"1461"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8899999856948853},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.8809999823570251},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.8579999804496765},{"id":"https://openalex.org/keywords/cost-minimization","display_name":"cost minimization","score":0.796999990940094},{"id":"https://openalex.org/keywords/personnel-costs","display_name":"personnel costs","score":0.7250000238418579},{"id":"https://openalex.org/keywords/time-and-motion-study","display_name":"time and motion study","score":0.5270000100135803},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9349141120910645},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8840444684028625},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6433236002922058},{"id":"https://openalex.org/C2781072439","wikidata":"https://www.wikidata.org/wiki/Q5174738","display_name":"Cost-minimization analysis","level":2,"score":0.4635303318500519},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39977502822875977},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3187980055809021}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D061605","descriptor_name":"Administration, Intravenous","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1007/s12094-017-1684-4","doi":"https://doi.org/10.1007/s12094-017-1684-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12094-017-1684-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12094-017-1684-4.pdf","source":{"id":"https://openalex.org/S179824187","display_name":"Clinical & Translational Oncology","issn_l":"1699-048X","issn":["1699-048X","1699-3055"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5700215","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5700215","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Transl Oncol","raw_type":"Text"},{"id":"pmid:28577152","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28577152","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","raw_type":"Journal Article"},{"id":"pmh:oai:www.repositoriosalud.es:10668/11267","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700215/pdf","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs12094-017-1684-4.pdf","source":{"id":"https://openalex.org/S4377196114","display_name":"RISalud Institutional Health Repository of Andaluc\u00eda","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"research article"},{"id":"pmh:oai:dnet:ricscm______::d4d632fb927531e747f3d77fd4d3c58a","doi":null,"is_oa":true,"landing_page_url":"https://repositoriosaludmadrid.es/handle/20.500.12530/31646","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.repositoriosalud.es:10668/18657","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10668/18657","pdf_url":null,"source":{"id":"https://openalex.org/S4377196114","display_name":"RISalud Institutional Health Repository of Andaluc\u00eda","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"research article"}],"best_oa_location":{"id":"doi:10.1007/s12094-017-1684-4","doi":"https://doi.org/10.1007/s12094-017-1684-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12094-017-1684-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12094-017-1684-4.pdf","source":{"id":"https://openalex.org/S179824187","display_name":"Clinical & Translational Oncology","issn_l":"1699-048X","issn":["1699-048X","1699-3055"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2621391008.pdf","grobid_xml":"https://content.openalex.org/works/W2621391008.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W947017752","https://openalex.org/W1988149797","https://openalex.org/W1997514259","https://openalex.org/W2000170834","https://openalex.org/W2003225345","https://openalex.org/W2024903800","https://openalex.org/W2085995337","https://openalex.org/W2091276904","https://openalex.org/W2101816047","https://openalex.org/W2105505359","https://openalex.org/W2107103026","https://openalex.org/W2117922713","https://openalex.org/W2138727105","https://openalex.org/W2269901519","https://openalex.org/W2313056116","https://openalex.org/W2315066014","https://openalex.org/W2316372113","https://openalex.org/W2431208164","https://openalex.org/W2763711876"],"related_works":["https://openalex.org/W1999755524","https://openalex.org/W2773709250","https://openalex.org/W2914573828","https://openalex.org/W1988149797","https://openalex.org/W1990347482","https://openalex.org/W2330930594","https://openalex.org/W2592999238","https://openalex.org/W4389279838","https://openalex.org/W2315066014","https://openalex.org/W4243676040"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"describe":[2],"healthcare":[3],"professional":[4],"(HCP)":[5],"and":[6,9,18,35,59,62,87,144,148,162,192,197,219,221,239],"patient":[7,83,168],"time":[8,55,65,86,122,161,177,215],"related":[10],"costs":[11,92,99,188,224],"associated":[12],"with":[13,25],"trastuzumab":[14,19,57,110,226],"intravenous":[15],"infusion":[16,84],"(IV)":[17],"subcutaneous":[20],"(SC)":[21],"formulations":[22],"in":[23,38,119,159,167,173,178,236],"patients":[24],"HER2-positive":[26],"early":[27],"breast":[28],"cancer.":[29],"METHODS:":[30],"This":[31],"prospective,":[32],"observational":[33],"time,":[34,171],"motion":[36],"study":[37],"three":[39],"Spanish":[40,102],"centers":[41],"was":[42],"run":[43],"as":[44,66],"a":[45,116,155,163,200,206],"substudy":[46],"of":[47,70,202,231,242],"the":[48,67,179,229],"PrefHer":[49],"trial.":[50],"We":[51,80],"recorded":[52],"active":[53,120],"HCP":[54,64,121,218],"for":[56,195,217],"SC":[58,113,151,212],"IV-related":[60],"tasks":[61],"calculated":[63,81,94],"mean":[68,82],"sum":[69],"task":[71],"times":[72],"over":[73,205],"154":[74],"administrations":[75],"(80":[76],"IV,":[77],"74":[78],"SC).":[79],"chair":[85,160],"treatment":[88,169,181,208],"room":[89,170],"time.":[90],"Staff":[91],"were":[93,189],"using":[95],"fully":[96],"loaded":[97],"salary":[98],"based":[100],"on":[101],"salaries":[103],"(\u20ac":[104],"2012).":[105],"RESULTS:":[106],"The":[107],"transition":[108],"from":[109,139],"IV":[111,141,196],"to":[112,115,154],"led":[114,153],"50%":[117],"reduction":[118,157,165],"[27.2":[123],"min":[124,130],"(95%":[125,131],"CI":[126,132],"21.8-32.6)":[127],"vs.":[128,225],"13.2":[129],"8.9-17.5)":[133],"per":[134],"cycle].":[135],"Time":[136],"savings":[137,216,238],"resulted":[138],"avoiding":[140],"catheter":[142],"installation":[143],"removal,":[145],"line":[146],"flushing,":[147],"drug":[149],"reconstitution.":[150],"administration":[152],"fivefold":[156],"(78-85%)":[158],"fourfold":[164],"(59-81%)":[166],"resulting":[172],"24":[174],"h":[175],"free-up":[176],"total":[180],"course":[182],"(18":[183],"cycles).":[184],"Total":[185],"estimated":[186],"direct":[187],"\u20ac":[190,193,203],"29,431.75":[191],"28,452.12":[194],"SC,":[198],"respectively,":[199],"saving":[201],"979.60":[204],"full":[207],"course.":[209],"CONCLUSIONS:":[210],"Trastuzumab":[211],"provided":[213],"substantial":[214],"patients,":[220],"reduced":[222],"staff":[223],"IV.":[227],"Reducing":[228],"use":[230],"hospital":[232],"facilities":[233],"may":[234],"result":[235],"further":[237],"improved":[240],"quality":[241],"medical":[243],"care.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-06-09T00:00:00"}